基于前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描的淋巴结图谱用于复发性前列腺癌挽救性放疗:对NRG Oncology 2020新指南的验证
该研究基于1653例生化复发前列腺癌患者的PSMA PET/CT数据筛选后,用233例患者数据构建淋巴结图谱,评估RTOG 2009与NRG 2020指南对淋巴结的覆盖情况。结果显示NRG 2020指南较RTOG 2009显著改善盆腔淋巴结覆盖(p < 0.001),但仍有39%淋巴结未被覆盖,作者建议尽可能考虑PET/CT以覆盖不典型淋巴结播散。
要点
- NRG 2020指南较RTOG 2009显著改善盆腔淋巴结覆盖(p < 0.001)。
- 使用NRG 2020指南时,39%淋巴结未被覆盖,24%部分覆盖,37%完全覆盖。
- 作者建议尽可能考虑PET/CT以确保覆盖不典型淋巴结播散。
核心结论
- 更新的NRG 2020轮廓指南改善了挽救性放疗患者的盆腔淋巴结覆盖。
- 作者认为应尽可能考虑PET/CT以确保覆盖不典型淋巴结播散。
研究设计与样本
- 研究筛选了2012年11月至2017年11月期间接受PET扫描的1653例生化复发患者的PSMA PET/CT数据集。
- 筛选后使用233例患者的数据构建淋巴结图谱,评估淋巴结与RTOG 2009及NRG 2020轮廓指南的重叠情况。
主要发现
- 与RTOG 2009指南相比,总体队列中403个(52%)淋巴结未被覆盖,134个(17%)部分覆盖,241个(31%)完全覆盖。
- 使用NRG 2020指南时,302个(39%)淋巴结未被覆盖,190个(24%)部分覆盖,286个(37%)完全覆盖(p < 0.001)。
关键数值与推荐
- 淋巴结重叠定义为:完全在范围内(>90%)、部分在范围内(10-90%)或范围外(<10%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 局限性包括回顾性设计、数据缺失以及PET结果无组织病理学确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Approximately 20-40% of patients with prostate cancer (PC) who undergo radical prostatectomy (RP) experience relapse, with the majority of these cases developing pelvic lymph node (LN) metastases. Taking new data from the prostate-specific membrane antigen (PSMA) positron emission tomography (PET) era into account, the Radiation Therapy Oncology Group (RTOG) 2009 contouring guideline for the pelvic LNs from 2009 was updated by the NRG Oncology group in 2020 (NRG 2020). OBJECTIVE: To evaluate and validate the updated NRG 2020 guideline with our established LN atlas. DESIGN, SETTING, AND PARTICIPANTS: We screened 1653 PSMA PET/computed tomography (CT) data sets for patients with biochemical relapse who underwent a PET scan between November 2012 and November 2017. After screening, we developed an LN atlas using data from 233 patients. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We evaluated LN overlap (OL) with the RTOG 2009 and NRG 2020 contouring guidelines. OL was defined as within (>90%), partly within (10-90%), or outside (<10%). RESULTS AND LIMITATIONS: In comparison to the RTOG 2009 guideline, 403 (52%), 134 (17%), and 241 (31%) of the LNs were not, were partly, or were fully covered within the overall group, respectively. By contrast, using the NRG 2020 guideline, 302 (39%), 190 (24%), and 286 (37%) of the LNs were not, were partly, or were fully covered, respectively (p < 0.001). Limitations include the retrospective design with missing data and no histopathological confirmation of the PET results. CONCLUSIONS: The updated NRG 2020 contouring guideline improves coverage of the pelvic LNs in patients undergoing salvage radiation therapy. However, PET/CT should be considered whenever possible to ensure coverage of untypical LN spread. PATIENT SUMMARY: We compared the 2009 and 2020 guidelines on the radiation area for the pelvis for patients with recurrent prostate cancer that has spread to lymph nodes. The newer guideline provides better coverage of pelvic lymph nodes than the older one and is useful in planning radiation therapy. However, a scan of the pelvis using the newest technique should be considered for individual patients to ensure coverage of untypical lymph nodes.
引用
- Vogel MME, Düsberg M, Stöhrer L, et al. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline. Eur Urol Oncol. 2022. PMID: 36280446. doi:10.1016/j.euo.2022.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。